Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to $1.3 million.

  • Healthcare Triangle's Accounts Payables fell 4308.09% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 4308.09%. This contributed to the annual value of $2.5 million for FY2024, which is 3000.51% up from last year.
  • Healthcare Triangle's Accounts Payables amounted to $1.3 million in Q3 2025, which was down 4308.09% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Healthcare Triangle's Accounts Payables ranged from a high of $2.6 million in Q3 2021 and a low of $926000.0 during Q2 2023
  • Its 5-year average for Accounts Payables is $1.7 million, with a median of $1.6 million in 2025.
  • As far as peak fluctuations go, Healthcare Triangle's Accounts Payables crashed by 5693.89% in 2021, and later surged by 10917.93% in 2024.
  • Healthcare Triangle's Accounts Payables (Quarter) stood at $1.9 million in 2021, then decreased by 20.93% to $1.5 million in 2022, then surged by 31.87% to $2.0 million in 2023, then skyrocketed by 30.01% to $2.5 million in 2024, then plummeted by 48.48% to $1.3 million in 2025.
  • Its Accounts Payables stands at $1.3 million for Q3 2025, versus $2.1 million for Q2 2025 and $1.6 million for Q1 2025.